Table 5

Univariate and multivariable analysis of poor prognostic factors and risk factors for recurrence in patients with stage I non-small cell lung cancer

VariablesUnivariate analysisMultivariate analysis
HR95% CIP-valueHR95% CIP-value
Age (years)<6510.001*10.047*
>651.5111.176 to 1.9421.2951.003 to 1.672
GenderWomen10.001*
Men1.5471.191 to 2.008Not included in multivariable model
Smoking habitsNon-smoker1<0.001*
Ever smoker1.7991.368 to 2.366Not included in multivariable model
FEV1/FVC (%)>7010.001*
<701.6051.223 to 2.108Not included in multivariable model
CEAWithin normal range10.001*
Elevated1.5271.186 to 1.967Not included in multivariable model
Tumor size (cm)<3.01<0.001*10.023*
>3.02.3841.861 to 3.0541.3661.044 to 1.786
Histological typeAdenocarcinoma10.001*
Non-adenocarcinoma1.7321.336 to 2.243Not included in multivariable model
Histological differentiationWell differentiated1<0.001*10.001*
Moderately/poorly differentiated3.4542.517 to 4.4401.8311.299 to 2.582
Lymphatic permeationAbsent1<0.001*10.031*
Present2.1751.672 to 2.8301.3511.027 to 1.777
Intratumoral vascular invasionAbsent1<0.001*1<0.001*
Present4.2423.274 to 5.4962.4871.838 to 3.366
Visceral pleural invasionAbsent1<0.001*10.001*
Present2.9532.291 to 3.8071.5941.210 to 2.099
  • * Indicates significance.

  • CEA, preoperative serum carcinoembryonic antigen level (normal upper limit 5 ng/ml); FEV1/FVC, forced expiratory volume in 1 s to forced vital capacity ratio; HR, HR for recurrence.